Arrowhead Research | ARWR - Current Liabilities

Stock Price
71.26
Daily Change
1.93 2.78%
Monthly
7.34%
Yearly
258.45%
Q1 Forecast
67.19

Arrowhead Research reported $195.49M in Current Liabilities for its fiscal quarter ending in September of 2025.





Current Liabilities Change Date
Agios Pharmaceuticals USD 74.76M 4.35M Sep/2025
Alnylam Pharmaceuticals USD 1.56B 254.63M Sep/2025
Arrowhead Research USD 195.49M 957K Sep/2025
Incyte USD 1.34B 60.11M Sep/2025
Ionis Pharmaceuticals USD 903.46M 6.22M Sep/2025
Ligand Pharmaceuticals USD 30.54M 34.2M Sep/2025
Merck USD 28.63B 2.59B Sep/2025
Moderna USD 1.68B 109M Sep/2025
Novartis USD 32B 286M Sep/2025
Sarepta Therapeutics USD 921.42M 1.48M Sep/2025
TG Therapeutics USD 156.81M 15.08M Sep/2025
Ultragenyx Pharmaceutical USD 340.02M 46.78M Sep/2025
Vertex Pharmaceuticals USD 4.48B 336.9M Sep/2025
Xencor USD 86.48M 9.6M Sep/2025